WO2015019238A8 - Process for the preparation of n-protected (5s)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-one - Google Patents
Process for the preparation of n-protected (5s)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-one Download PDFInfo
- Publication number
- WO2015019238A8 WO2015019238A8 PCT/IB2014/063486 IB2014063486W WO2015019238A8 WO 2015019238 A8 WO2015019238 A8 WO 2015019238A8 IB 2014063486 W IB2014063486 W IB 2014063486W WO 2015019238 A8 WO2015019238 A8 WO 2015019238A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- thiazolidin
- pyrrolidin
- ylcarbonyl
- protected
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
The present invention provides a process for the preparation of an N-protected (5S)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-one of Formula III. The invention also provides a process for the preparation of {(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5- yl)piperazin-1-yl]pyrrolidin-2-yl}(1,3-thiazolidin-3-yl)methanone, or salts thereof, using the N-protected (5S)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-one of Formula III.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2347/DEL/2013 | 2013-08-06 | ||
IN2347DE2013 | 2013-08-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2015019238A1 WO2015019238A1 (en) | 2015-02-12 |
WO2015019238A8 true WO2015019238A8 (en) | 2015-04-16 |
Family
ID=51355590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2014/063486 WO2015019238A1 (en) | 2013-08-06 | 2014-07-28 | Process for the preparation of n-protected (5s)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-one |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015019238A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105153005A (en) * | 2015-08-05 | 2015-12-16 | 上海瑞博化学有限公司 | Preparation method of 4-carbonyl-proline derivative |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104788353B (en) * | 2015-04-07 | 2018-04-20 | 四川同晟氨基酸有限公司 | A kind of method for synthesizing 4 oxo L proline derivatives |
CN105085510B (en) * | 2015-09-11 | 2018-03-02 | 沧州那瑞化学科技有限公司 | A kind of preparation method of the carboxylic acid tert-butyl ester of (S) 4 oxo 2 (carbonyl of thiazolidine 3) pyrrolidines 1 |
JP2019512460A (en) * | 2017-02-03 | 2019-05-16 | グレンマーク・ファーマシューティカルズ・リミテッド | Preparation containing oxalate salt of teneligliptin and solvate thereof |
JP6985179B2 (en) * | 2018-02-27 | 2021-12-22 | 田辺三菱製薬株式会社 | Method for producing proline amide compound |
CN110294748B (en) * | 2019-07-25 | 2020-12-25 | 浙江沙星科技有限公司 | Synthesis method of teneligliptin key intermediate |
CN115160306B (en) * | 2022-08-04 | 2024-03-26 | 上海皓鸿生物医药科技有限公司 | Synthetic method of telithromycin intermediate |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1950199B1 (en) | 2000-08-10 | 2009-12-02 | Mitsubishi Tanabe Pharma Corporation | Proline derivatives and use thereof as drugs |
GEP20084421B (en) * | 2004-05-12 | 2008-07-10 | Pfizer Prod Inc | Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
BRPI0607863B8 (en) | 2005-02-18 | 2021-05-25 | Mitsubishi Pharma Corp | 3-{(2s,4s)-4-[4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl crystalline salt }thiazolidine and its preparation process |
CN103619334A (en) * | 2011-01-19 | 2014-03-05 | 朱红文 | Thiazolidine derivatives and therapeutic use thereof |
JP5863789B2 (en) * | 2011-06-01 | 2016-02-17 | 田辺三菱製薬株式会社 | Method for producing pyrazole derivative |
BR112015004029B1 (en) * | 2012-08-31 | 2022-03-29 | Glenmark Pharmaceuticals Limited | Process for preparing teneligliptin, a compound or a salt or hydrate thereof |
-
2014
- 2014-07-28 WO PCT/IB2014/063486 patent/WO2015019238A1/en active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105153005A (en) * | 2015-08-05 | 2015-12-16 | 上海瑞博化学有限公司 | Preparation method of 4-carbonyl-proline derivative |
Also Published As
Publication number | Publication date |
---|---|
WO2015019238A1 (en) | 2015-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015019238A8 (en) | Process for the preparation of n-protected (5s)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-one | |
ZA201906909B (en) | Fungicidal oxadiazoles | |
BR112018076558A2 (en) | cyclohexyl carbamoyloxymethyl triazole acids as lpa antagonists | |
PH12017500361B1 (en) | Novel compounds | |
ZA201701299B (en) | Glycosidase inhibitors | |
MY171055A (en) | 3,5-disubstituted alkynylbenzene compound and salt thereof | |
GEP20207111B (en) | Heteroaryl compounds for kinase inhibition | |
EA201591506A1 (en) | Heterocyclic Amines As Kinase Inhibitors | |
EA201590920A1 (en) | Heteroaryl-Substituted Pyridyl Compounds Applied as Kinase Modulators | |
SG10201805628TA (en) | Deuterated heterocyclic compounds and their use as imaging agents | |
MX2015015130A (en) | Biheteroaryl compounds and uses thereof. | |
NZ704147A (en) | Partially saturated nitrogen-containing heterocyclic compound | |
MY185491A (en) | Macrocylic pyrimidine derivatives | |
MX2014015511A (en) | Fungicidal heterocyclic compounds. | |
PH12020550905A1 (en) | Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives | |
MX2017009292A (en) | (r)-2-methyl-piperazine derivatives as cxcr3 receptor modulators. | |
AU2015292632B2 (en) | Aldosterone synthase inhibitors | |
WO2016100302A3 (en) | Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof | |
PH12016500134B1 (en) | 1-(piperazin-1-yl) -2- ([1,2,4] triazol -1- yl) - ethanone derivatives | |
MY178583A (en) | Hydantoin derivative | |
MX2016004560A (en) | Process for preparing 4-[[(benzoyl)amino]sulphonyl]benzoyl chlorides and preparation of acylsulphamoylbenzamides. | |
MX2017008074A (en) | IMIDAZOPYRIDAZINE DERIVATIVES AS PI3Kß INHIBITORS. | |
WO2015111004A3 (en) | Improved process for the preparation of chlorophenyl trifluoroethanone | |
MX2022001861A (en) | Process of preparing 2-(phenylimino)-3-alkyl-1,3-thiazolidin-4-on es. | |
IN2014KN02951A (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14752427 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14752427 Country of ref document: EP Kind code of ref document: A1 |